Broker Tips
Broker tips: Shell, Astrazeneca, Croda
Berenberg upgraded its stance on shares of oil giant Royal Dutch Shell to ‘buy’ from ‘hold’ on Wednesday, noting the stock has fallen around 50% this year.
UBS downgrades InterContinental Hotels, says recent rally was premature
UBS cut its stance on InterContinental Hotels on Wednesday to ‘sell’ from ‘neutral’, arguing that the recent rally was premature, new risks are underappreciated and the stock is "priced for perfection in an uncertain recovery".
Berenberg upgrades Shell to 'buy'
Berenberg upgraded its stance on shares of oil giant Royal Dutch Shell to ‘buy’ from ‘hold’ on Wednesday, noting the stock has fallen around 50% this year.
Bank of America upgrades easyJet, IAG on positive vaccine data
Bank of America Merrill Lynch upgraded easyJet and International Consolidated Airlines Group on Wednesday following the positive update on a potential Covid-19 vaccine.
RBC Capital upgrades UDG Healthcare to 'outperform'
RBC Capital Markets upgraded its rating on shares of UDG Healthcare on Wednesday to ‘outperform’ from ‘sector perform’ and hiked the price target to 880p from 800p, saying it was "time to get more positive".
SocGen cuts Meggitt to 'sell' after shares leap on vaccine hopes
Societe Generale downgraded Meggitt to 'sell' after the company's shares jumped following the news that an effective Covid-19 vaccine was in the pipeline.
HSBC upgrades AstraZeneca on vaccine newsflow
HSBC upgraded AstraZeneca to 'hold' based on stronger commercial delivery and expected further good news about Covid-19 vaccines.
Canaccord initiates coverage on Pantheon Resources at 'speculative buy'
Analysts at Canaccord Genuity initiated coverage on oil and gas company Pantheon Resources with a 76. 0p target price and a 'speculative buy' rating on Wednesday.
JPMorgan downgrades Croda on valuation
JPMorgan Cazenove downgraded its stance on shares of specialty chemicals company Croda International on Wednesday to ‘underweight’ from ‘neutral’, pointing to an expensive valuation and already full 2021 consensus.